English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Both the innate and adaptive immune systems play a central role in the surveillance and control of neoplasia. A source of much recent attention, tumor infiltrating lymphocytes (TILs) are a population of T-cells, which have a greater degree of immunological reactivity against neoplastic cells, as compared with circulating (non-tumor infiltrating) lymphocytes. Given the key role that they play, TILs have been explored as prognostic biomarkers for a number of solid organ malignancies, including breast cancer (1), head and neck cancers (2), melanoma (3), colorectal cancer (4), non-small cell lung cancer (5), malignant pleural mesothelioma (6), and esophageal cancer (7).

annals of translational medicine

Percentage of tumor-infiltrating lymphocytes after chemoradiation therapy for locally advanced esophageal squamous cell carcinoma: a biomarker for pathological response rates and cancer-specific survival?